The Journal of Immunology, Vol 146, Issue 11 3964-3970, Copyright © 1991 by American Association of Immunologists

ARTICLES

Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex

SK Kochi, RC Johnson and AP Dalmasso
Department of Microbiology, University of Minnesota Medical School, Minneapolis.

Lyme disease is a multisystemic illness caused by the spirochete Borrelia burgdorferi. In the absence of specific antibody, the spirochete is resistant to the bactericidal activity of C, despite the capacity of B. burgdorferi to activate both C pathways. We examined the mechanism of serum resistance by measuring the deposition of C3 and terminal C components on B. burgdorferi in the presence and absence of immune IgG. In normal human serum antibody-sensitized borreliae bound similar amounts of C3, and similar or increased amounts of C8 and C9, in comparison to unsensitized bacteria. However, at comparable levels of C3, C8, or C9 uptake, only sensitized bacteria were killed. The requirement of antibody for killing could not be explained by differences in the rate of C deposition or by differences in the C9 to C8 ratio in the membrane attack complex (MAC). We found that bacteria incubated in C5-depleted human serum, but not in C6-depleted serum, were killed when this treatment was followed by antibody and the missing C components. Bacteria were also killed by reactive lysis (C5b- 9) provided that antibody was present. Therefore, the effect of bactericidal IgG occurred at the stage of C5b binding to the bacterial surface. Elution studies of bound C9 indicated that the MAC was stably bound to the outer membrane of B. burgdorferi, whether or not the bacteria were treated with antibody. However, treatment with 0.1% trypsin released 48% of 125I-C9 from the surface of unsensitized borreliae and 24% from IgG-sensitized cells, demonstrating that the presence of the antibody changed the accessibility to trypsin of C9 in the MAC. These results indicate that the effect of antibody in the killing process is not to enhance the rate or extent of initial or terminal component binding, but rather to alter the bacterial outer membrane to allow effective MAC formation.

This article has been cited by other articles:

				T. Bykowski, M. E. Woodman, A. E. Cooley, C. A. Brissette, V. Brade, R. Wallich, P. Kraiczy, and B. Stevenson Coordinated Expression of Borrelia burgdorferi Complement Regulator-Acquiring Surface Proteins during the Lyme Disease Spirochete's Mammal-Tick Infection Cycle Infect. Immun., September 1, 2007; 75(9): 4227 - 4236. [Abstract] [Full Text] [PDF]

				C. S. Brooks, S. R. Vuppala, A. M. Jett, and D. R. Akins Identification of Borrelia burgdorferi Outer Surface Proteins Infect. Immun., January 1, 2006; 74(1): 296 - 304. [Abstract] [Full Text] [PDF]

				M. Guerau-de-Arellano, J. Alroy, and B. T. Huber {beta}2 Integrins Control the Severity of Murine Lyme Carditis Infect. Immun., June 1, 2005; 73(6): 3242 - 3250. [Abstract] [Full Text] [PDF]

				C. L. Gipson and A. M. de Silva Interactions of OspA Monoclonal Antibody C3.78 with Borrelia burgdorferi within Ticks Infect. Immun., March 1, 2005; 73(3): 1644 - 1647. [Abstract] [Full Text] [PDF]

				D. A. Jobe, S. D. Lovrich, R. F. Schell, and S. M. Callister C-Terminal Region of Outer Surface Protein C Binds Borreliacidal Antibodies in Sera from Patients with Lyme Disease Clin. Vaccine Immunol., July 1, 2003; 10(4): 573 - 578. [Abstract] [Full Text] [PDF]

				M. Pausa, V. Pellis, M. Cinco, P. G. Giulianini, G. Presani, S. Perticarari, R. Murgia, and F. Tedesco Serum-Resistant Strains of Borrelia burgdorferi Evade Complement-Mediated Killing by Expressing a CD59-Like Complement Inhibitory Molecule J. Immunol., March 15, 2003; 170(6): 3214 - 3222. [Abstract] [Full Text] [PDF]

				S. Rathinavelu, A. Broadwater, and A. M. de Silva Does Host Complement Kill Borrelia burgdorferi within Ticks? Infect. Immun., February 1, 2003; 71(2): 822 - 829. [Abstract] [Full Text] [PDF]

				S. M. Callister, D. A. Jobe, W. A. Agger, R. F. Schell, T. J. Kowalski, S. D. Lovrich, and J. A. Marks Ability of the Borreliacidal Antibody Test To Confirm Lyme Disease in Clinical Practice Clin. Vaccine Immunol., July 1, 2002; 9(4): 908 - 912. [Abstract] [Full Text] [PDF]

				A. Alitalo, T. Meri, L. Ramo, T. S. Jokiranta, T. Heikkila, I. J. T. Seppala, J. Oksi, M. Viljanen, and S. Meri Complement Evasion by Borrelia burgdorferi: Serum-Resistant Strains Promote C3b Inactivation Infect. Immun., June 1, 2001; 69(6): 3685 - 3691. [Abstract] [Full Text] [PDF]

				F. T. Liang, M. B. Jacobs, and M. T. Philipp C-Terminal Invariable Domain of VlsE May Not Serve as Target for Protective Immune Response against Borrelia burgdorferi Infect. Immun., March 1, 2001; 69(3): 1337 - 1343. [Abstract] [Full Text] [PDF]

				P. KRAICZY, K.-P. HUNFELD, S. PETERS, R. WURZNER, G. ACKER, B. WILSKE, and V. BRADE Borreliacidal activity of early Lyme disease sera against complement-resistant Borrelia afzelii FEM1 wild-type and an OspC-lacking FEM1 variant J. Med. Microbiol., October 1, 2000; 49(10): 917 - 928. [Abstract] [Full Text] [PDF]

				F. T. Liang, J. M. Nowling, and M. T. Philipp Cryptic and Exposed Invariable Regions of VlsE, the Variable Surface Antigen of Borrelia burgdorferi sl J. Bacteriol., June 15, 2000; 182(12): 3597 - 3601. [Abstract] [Full Text]

				M. M. Exner, X. Wu, D. R. Blanco, J. N. Miller, and M. A. Lovett Protection Elicited by Native Outer Membrane Protein Oms66 (p66) against Host-Adapted Borrelia burgdorferi: Conformational Nature of Bactericidal Epitopes Infect. Immun., May 1, 2000; 68(5): 2647 - 2654. [Abstract] [Full Text] [PDF]

				A. P. Dalmasso, B. A. Benson, J. S. Johnson, C. Lancto, and M. S. Abrahamsen Resistance Against the Membrane Attack Complex of Complement Induced in Porcine Endothelial Cells with a Gal{alpha}(1-3)Gal Binding Lectin: Up-Regulation of CD59 Expression J. Immunol., April 1, 2000; 164(7): 3764 - 3773. [Abstract] [Full Text] [PDF]

				M. Sole, C. Bantar, K. Indest, Y. Gu, R. Ramamoorthy, R. Coughlin, and M. T. Philipp Borrelia burgdorferi Escape Mutants That Survive in the Presence of Antiserum to the OspA Vaccine Are Killed When Complement Is Also Present Infect. Immun., June 1, 1998; 66(6): 2540 - 2546. [Abstract] [Full Text] [PDF]

				K. E. Hagman, P. Lahdenne, T. G. Popova, S. F. Porcella, D. R. Akins, J. D. Radolf, and M. V. Norgard Decorin-Binding Protein of Borrelia burgdorferi Is Encoded within a Two-Gene Operon and Is Protective in the Murine Model of Lyme Borreliosis Infect. Immun., June 1, 1998; 66(6): 2674 - 2683. [Abstract] [Full Text] [PDF]

				M.-C. Shanafelt, I. Kang, S. W. Barthold, and L. K. Bockenstedt Modulation of Murine Lyme Borreliosis by Interruption of the B7/CD28 T-Cell Costimulatory Pathway Infect. Immun., January 1, 1998; 66(1): 266 - 271. [Abstract] [Full Text] [PDF]